Document:

SECURITIES PURCHASE AGREEMENT

THIS SECURITIES PURCHASE AGREEMENT (this "Agreement"), is made as of April __,
2001 by and between Innovative Medical Services, a corporation organized under
the laws of the State of California (the "Company" and xxxxxxxxxxxxx. (the
"Buyer").

RECITALS

A. The Company and the Buyer are executing and delivering this Agreement in
reliance upon the exemption from securities registration afforded by the
provisions of Regulation D ("Regulation D" as promulgated by the United States
Securities and Exchange Commission (the "SEC") under the Securities Act of 1933,
as amended (the "1933 Act"), Regulation S ("Regulation S" as promulgated by the
SEC and Section 4(2) under the 1933 Act;

B. The Buyer desires to purchase from the Company, and the Company desires to
sell to the Buyer, for the amounts and upon the terms and conditions stated in
this Agreement, in a closing (the "Closing" as herein described, a $100,000
principal amount Convertible Debenture, the form of which is attached hereto as
Exhibit A (the "Debenture"), which may be converted into Units each consisting
of one share of common stock and one Common Stock Purchase Warrant ("Units"),
upon the terms and conditions hereof and upon the terms and conditions of the
Debenture and the Warrant contained in the Units. The Units into which the
Debenture may (in accordance with its terms) be convertible shall be
collectively preferred to herein as the "Conversion Units." The Debenture and
the Conversion Units shall be collectively referred to herein as the
"Securities."

                                   AGREEMENTS

NOW, THEREFORE, in consideration of their respective promises contained herein
and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged by the parties, the Company and the Buyer hereby agree
as follows:

1. PURCHASE AND SALE OF SECURITIES.

a.   Purchase. The Buyer hereby agrees to purchase from the Company, and the
     Company agrees to sell to the Buyer, the Debenture at the Closing. The
     purchase price (the "Purchase Price") for the Debenture purchased at the
     Closing shall be $100,000 in immediately available funds by cashiers check
     or wire transfer.

b.   Closing Date The date of the Closing (the "Closing Date") shall be April
     30, 2001

c.   Escrow and Closing. The Buyer and the Company appoint Dennis Brovarone,
     Attorney at Law to serve as Escrow Agent for the Closing of this Purchase
     Agreement. The Escrow and the Closing of this Purchase Agreement shall be
     as follows:

     i.   On or before the next business day the Purchase Agreement has been
          executed by the Buyer and accepted by the Company, the Buyer shall
          deliver to the Escrow Agent, The Purchase Price by wire transfer to
          the Escrow Agent as follows:

                  Dennis Brovarone, Attorney at Law
                  COLTAF Account Bank One Colorado
                  ABA # 550 101 022 Acct # 190 783 306.

     ii.  On or before the second business day on which the Escrow Agent has
          notified the Company of the Purchase Price, the Company shall deliver
          to the Escrow Agent, an original Convertible Debenture registered in
          the name of the Purchaser and its Wire Instructions. If the Debenture
          is not delivered within three business days of the Escrow Agent's
          confirmation of the receipt of funds, the Escrow shall provide notice
          to the Company and the Buyer of such non-receipt and the deposited
          funds shall be returned to the Investor without charge or interest
          upon the Buyer's written request.

     iii. On or before the next business day after the Escrow Agent's receipt of
          the Debenture, the Escrow Agent shall wire transfer the Purchase to
          the Company.

     iv.  The Buyer and the Company shall indemnify and hold harmless the Escrow
          Agent from any and all liability for performance under this Agreement.
          The Escrow Agent shall have the right to file an Interpleader Action
          in the Colorado State courts should any dispute arise between the
          parties as to the right, title or interest in any funds or securities
          deposited with the Escrow Agent as a result of this Agreement.

2. BUYER'S REPRESENTATIONS AND WARRANTIES

The Buyer understands, agrees with, and represents and warrants to the Company
with respect to its purchase hereunder, that:

a. Investment Purposes: Compliance With 1933 Act. The Buyer is purchasing the
Securities for its own account for investment only and not with a view towards,
or in connection 'with, the public sale or distribution thereof, except pursuant
to sales registered under or exempt from the 1933 Act. The Buyer is not
purchasing the Securities for the purpose of covering short sale positions in
the Common Stock established on or prior to the Closing Date. The Buyer agrees
to offer, sell or otherwise transfer the Securities only (i) in accordance with
the terms of this Agreement and the Debentures, as applicable, and (ii) pursuant
to registration under the 1933 Act or to an exemption from registration under
the 1933 Act and any other applicable securities laws. The Buyer does not by its
representations contained in this Section 2(a) agree to hold the Securities for
any minimum or other specific term and reserves the right to dispose of the
Securities at any time pursuant to a registration statement or in accordance
with an exemption from registration under the 1933 Act, in all cases in
accordance with applicable state and federal securities laws. The Buyer
understands that it shall be a condition to the issuance of the Conversion
Shares that the Conversion Shares be and are subject to the representations set
forth in this Section 2(a).

b. Accredited Investor Status. The Buyer is an "accredited investor" as that
term is defined in Rule 501 (a) of Regulation D. The Buyer has such knowledge
and experience in financial and business matters that it is capable of
evaluating the merits and risks of an investment made pursuant to this
Agreement. The Buyer is aware that it may be required to bear the economic risk
of an investment made pursuant to this Agreement for an indefinite period of
time, and is able to bear such risk for an indefinite period.

c. Reliance on Exemptions. The Buyer understands the Securities are being
offered and sold to it in reliance on specific exemptions from the registration
requirements of the applicable United States federal and state securities laws
and that the Company is relying upon the truth and accuracy of, and the Buyer's
compliance with, the representations, warranties, acknowledgments,
understandings, agreements and covenants of the Buyer set forth herein in order
to determine the availability of such exemptions and the eligibility of the
Buyer to acquire the Securities.

d. Information. The Buyer and its advisors, if any, have been furnished with all
materials relating to the business, finances and operations of the Company and
materials relating to the offer and sale of the Securities that have been
requested by the Buyer. The Buyer and its advisors if any, have been afforded
the opportunity to ask all such questions of the Company as they have in their
discretion deemed advisable. The Buyer understands that its investment in the
Securities involves a high degree of risk. The Buyer has sought such accounting,
legal and tax advice as it. has considered necessary to an informed investment
decision with respect to the investment made pursuant to this Agreement.

e. No Government Review. The Buyer understands that no United States federal or
state agency or any other government or governmental agency has passed on or
made any recommendation or endorsement of the Securities or the fairness or
suitability of the investment in the Securities, nor have such authorities
passed upon or endorsed the merits of the offering of the Securities.

f. Transfer or Resale. The Buyer understands that (i) the Securities have not
been and are not being registered under the 1933 Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless
either (a) subsequently registered thereunder or (b) the Buyer shall have
delivered to the Company an opinion by counsel reasonably satisfactory to the
Company, in form, scope and substance reasonably satisfactory to the Company, to
the . effect that the securities to be sold, assigned or transferred may be
sold, assigned or transferred pursuant to an exemption from such registration,
(ii) any sale of such securities made in reliance on Rule 144 (as hereafter
defined) may be made only in accordance with the terms of Rule 144 and further,
if Rule 144 is not applicable, any resale of such securities under circumstances
in which the seller (or the person though whom the sale is made) may be deemed
to be an underwriter (as that term is defined in the 1933 Act) may require
compliance with some other exemption under the 1933 Act or the rules and
regulations of the SEC thereunder, and (iii) neither the Company nor any other
person is under any obligation to register such securities under the 1933 Act or
any state securities laws or to comply with the terms and conditions of any
exemption thereunder (in each case, other than pursuant to this Agreement).

g. Legend. The Buyer understands that the Debenture and until such time as the
securities have been registered under the 1933 Act may be sold by the Buyer
pursuant to Rule 144 (as amended, or any applicable rule which operates to
replace said Rule) promulgated under the 1933 Act ("Rule l44"), the stock
certificates representing the Securities will bear a restrictive legend (the
"Legend") in substantially the following form:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "ACT'), OR APPLICABLE STATE SECURITIES LAWS
(COLLECTIVELY, THE "LAWS"). THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND
MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF
EITHER (I) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE
LAWS, OR (II) AN OPINION OF COUNSEL PROVIDED TO THE ISSUER IN FORM, SUBSTANCE
AND SCOPE REASONABLY ACCEPTABLE TO EIE ISSUER TO THE EFFECT THAT REGISTRATION IS
NOT REQUIRED UNDER THE LAWS DUE TO AN AVAILABLE EXCEPTION TO OR EXEMPTION FROM
THE REGISTRATION REQUIREMENTS OF THE LAWS.

The Legend shall be removed and the Company will issue certificates without the
Legend to the holder of the Debenture or any Securities upon which the Legend is
stamped, in accordance with Section 5(b).

h. Authorization: Enforcement. This Agreement and the Debenture have been duly
and validly authorized, executed and delivered by the Buyer and are each and
collectively valid and binding agreements of the Buyer enforceable in accordance
with their terms, subject as to enforceability to general principles of equity
and to bankruptcy, insolvency, morat6rium, and other similar laws affecting the
enforcement of creditors' rights generally.

3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

The Company understands, agrees with, and represents and warrants to the Buyer
that:

a. Organization and Qualification The Company and its subsidiaries are
corporations duly organized and existing in good standing under the laws of the
respective jurisdictions in which they are incorporated, except as would not
have a Material Adverse Effect (as defined below), and have the requisite
corporate power to own their properties and to carry on their business as now
being conducted. Each of the Company and its subsidiary is duly qualified as a
foreign corporation to do business mid is in good standing in every jurisdiction
in which the nature of the business conducted by it makes such qualification
necessary and where the failure so to qualify would have a Material Adverse
Effect. "Material Adverse Effect" means any material adverse effect on the
operations, properties or financial condition of the Company and its
subsidiaries taken as a whole.

b. Authorization: Enforcement. (i) The Company has the requisite corporate power
and authority to enter into and perform this Agreement and the Debenture, to
issue and sell the Debenture and the Securities in accordance with the terms
hereof, and to perform its obligations under the Debenture in accordance with
the requirements of the same, (ii) the execution, delivery mid performance of
this Agreement and the Debenture by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by
the Company's Board of Directors and no further consent or authorization of the
Company, its Board of Directors, or its stockholders is required, (iii) this
Agreement and, on the Closing Date, the Debenture sold at the Closing, have been
duly and validly authorized; executed and delivered by the Company, and (iv)
this Agreement and the Debenture (when issued), constitute the valid and binding
obligations of the Company enforceable against the Company in accordance with
their respective terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting, generally, the enforcement of creditors'
tights and remedies or by other equitable principles of general application.

c. Capitalization. As of April __, 2001, the authorized capital stock of the
Company consists of (i) 20,000,000 shares of Common Stock of which 6,625,752
shares were issued and outstanding, and. (ii) 5,000 shares of Preferred Stock of
which no shares were issued and outstanding; All of such outstanding shares have
been validly issued and are fully paid and non-assessable. No shares of Common
Stock are subject to preemptive rights or any other similar rights or any liens
or encumbrances.

d. Issuance of Securities. The Securities are all duly authorized and reserved
for issuance, arid in all cases upon issuance shall be validly issued, fully
paid and non-assessable, free from all taxes, liens and charges with respect to
the issue thereof, and will not be subject to preemptive rights or other similar
rights of stockholders of the Company.

e. No Conflicts. The execution, delivery and performance of this Agreement by
the Company and the consumption by the. Company of the transactions contemplated
hereby will n6t (i) result in a violation of the Certificate of Incorporation or
Bylaws or (il) conflict with' or constitute a default (or an event which with
notice or lapse of time or both would become a default under, or give to others
any rights of termination, amendment. acceleration or cancellation of; any
agreement, indenture or instrument to which the Company or any of its
subsidiaries is a party, or result in a violation of any law, rule, regulation,
order, judgment or decree. (including federal and state securities laws and
regulations) applicable to the Company or any of its subsidiaries or by which
any property or asset of the Company or any of its subsidiaries is bound or
affected (except for such conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect). Neither the Company nor any of its
subsidiaries is in violation of its Certificate of Incorporation or other
organizational documents, and neither the Company nor any of its subsidiaries is
in default (and no event has occurred which, with notice or lapse of time or
both, would put the Company or any of its subsidiaries in default) under, nor
has there occurred any event giving others (with notice or lapse of time or
both) any rights of termination, amendment, acceleration or cancellation of; any
agreement, indenture or instrument to which the Company or any of its
subsidiaries is a party, except for possible defaults or rights as would not, m
the aggregate or individually, have a Material Adverse Effect. The business of
the Company and its subsidiaries is not being conducted, and shall not be
conducted so long as the Buyer owns any of the Securities; in violation of any
law, ordinance or regulation of any governmental entity, except for possible
violations which neither singly or in the aggregate would have a Material
Adverse Effect. Except as specifically contemplated by this Agreement and as
required under the 1933 Act and any applicable state securities laws, the
Company is not required to obtain any consent, authorization or order of; or
make any filing or registration with, any court or governmental agency in order
for it to execute, deliver or perform any of its obligations under this
Agreement or the Debenture in accordance with the terms hereof and thereof, or
to perform its obligations with respect to the Debenture exactly as described in
the Debenture (once issued).

 f. Absence of Litigation There is no action, suit, proceeding, inquiry or
investigation before or by any court, public board or body pending or, to the
knowledge of the Company, threatened against or affecting the Company, wherein
an unfavorable decision, ruling or finding would have a Material Adverse Effect
or which would adversely affect die validity or enforceability of; or the
authority or ability of the Company to perform its obligations under, this
Agreement or any of the documents contemplated herein.

g. Brokers: No General Solicitation. The Company has taken no action that would
give rise to any claim by any person for brokerage commissions, finder's fees or
similar payments relating to this Agreement and the transactions contemplated
hereby. The Company and the Buyer both acknowledge that no broker or finder was
involved with respect to the transactions contemplated hereby. Neither the
Company nor any distributor participating on the Company's behalf in the
transactions contemplated hereby nor any person acting for the Company, or any
such distributor, has conducted any general solicitation," as described in Rule
502(c) under Regulation D, with respect to the Securities being offered hereby.

h. Securities Exchange Act Filings. The Company has timely filed all Securities
Exchange Act filings required of it for not less than the past twelve months and
that the Company is eligible to file an S-3 registration statement on behalf of
the Buyer as a selling securities holder. The Company further represents and
warrants that these Securities Exchange Act filings do not contain any
misstatements of material facts regarding the Company or omissions which render
the statements made therein misleading.

i. Registration of Securities: Within thirty days of closing of the this
Purchase Agreement, the Company shall file a registration statement on Form S-3
for twice the number of Conversion Shares as would be issued if the Debenture
were to be converted as of said thirtieth day. As and when the registration
statement is declared effective by the SEC and upon conversion, the Buyer may
publicly offer and sell the Conversion Shares pursuant to the Prospectus
contained within said registration statement. The Company shall provide the
Buyer with sufficient copies of the Prospectus. The Company makes no
representation as to when the registration statement will be declared effective.

j. Late Fee for Failure to File the Registration Statement: In the event the
Company fails to file the above registration on or before the thirtieth day
after closing of this Purchase Agreement, the Company agrees to pay the Buyer a
late fee of fifteen thousand dollars which shall be added to the principal of
the Debenture. Failure to File the Registration Statement shall also be an event
of default of the Debenture.

4. COVENANTS.

a. Best Efforts. Each party shall use its best efforts timely to satisfy each of
the conditions to be satisfied by it as provided in Sections 6 and 7 of this
Agreement.

b. Securities Laws. The Company agrees to timely file a Form D (or equivalent
form required by applicable state law) with respect to the Securities if and as
required under Regulation D and applicable state securities laws and to provide
a copy thereof to the Buyer promptly alter such filing. The Company shall, on or
before the Closing Date, take such action as is necessary to sell the Securities
being sold to the Buyer on each such date under applicable securities laws of
the United States, and shall if specifically so requested provide evidence of
any such action so taken to the Buyer on or prior to the Closing Date.

c. Reservation of Shares. The Company shall at all times have authorized, and
reserved for the purpose of issuance, a sufficient number of shares of Common
Stock to provide for the issuance of all of the Conversion Shares.

d. Conversion Restrictions. Notwithstanding anything to the contrary set forth
herein or in the Debenture, in no event shall any holder of the Debenture be
entitled to convert Debenture in excess of such portion of the principal of the
Debenture that, upon giving effect to such conversion, would cause the aggregate
number of shares of Common Stock beneficially owned by the holder and its
affiliates to exceed 9.99% of the outstanding shares of the Common Stock
following such conversion. For purposes of the foregoing proviso, the aggregate
number of shares of Common Stock beneficially owned by the holder and its
affiliates shall include the number of shares of Common Stock issuable upon
conversion of the Debenture with respect to which the determination of such
proviso is being made. Except as set forth in the preceding sentence, for
purposes of this Section 4(d), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Securities Exchange Act of 1934, as
amended. The limitations imposed by this Section 4(d) on conversion of Debenture
shall no longer apply, and the holder of the Debenture may convert all or any
portion of the Debenture, irrespective of the resulting beneficial ownership of
the Company's Common Stock, should any of the following events occur: (I) The
Company shall either. (i) become insolvent; (ii) admit in writing its inability
to pay its debts generally or as they become due; (iii) make an assignment for
the benefit of creditors or commence proceedings for its dissolution; or (iv)
apply for, or consent to the appointment of; a trustee, liquidator, or receiver
for its or for a substantial part of its property or business; or (II) A
trustee, liquidator or receiver shall be appointed for the Company or for a
substantial part of its property or business without the Company's consent and
such appointment is not discharged within sixty (60) days after such
appointment; or (III) Any governmental agency or any court of competent
jurisdiction at the instance of any governmental agency shall assume custody or
control of the whole or any substantial portion of the properties or assets of
the Company and shall not be dismissed within sixty (60) days thereafter; or
(IV) Any money judgment, writ or Debenture of attachment, or similar process in
excess of Two Hundred Thousand United States Dollars (US$200,000.00) in the
aggregate shall be entered or filed against the Company for any of its
properties or assets and shall remain unpaid, unvacated, unbonded or unstayed
for a period of fifteen (15) days or in any event later than five (5) days prior
to the date of any proposed sale thereunder; or (V) Bankruptcy, reorganization,
insolvency or liquidation proceedings or other proceedings for relief under any
bankruptcy law or any law for the relief of debtors shall be instituted by or
against the Company and, if instituted against the Company, shall not be
dismissed within sixty days after such institution or the Company shall by any
action or answer approve of, consent to, or acquiesce in any such proceedings or
admit the material allegations of or default in answering a petition filed in,
any such proceeding.

5. LEGEND AND TRANSFER INSTRUCTIONS.

a. Transfer Agent Instructions. The Company shall tender the irrevocable
instructions its transfer agent set forth in Exhibit 5.a attached hereto to
issue certificates, registered in the name of the Buyer or its nominee, for the
Conversion Shares in accordance with the terms of the applicable Debenture and
in such amounts as specified from time to time by the Buyer to the Company, upon
conversion of the Debenture. All such certificates shall bear the restrictive
legend specified in Section 1(g) of this Agreement only to the extent required
by applicable law and as specified in this Agreement and the Exhibits and
Addenda hereto. Nothing in this Section shall affect in any way the Buyer's
obligations and agreement to comply with all applicable securities laws upon
resale of the Conversion Shares.

b. Removal of Legends. The Legend shall be removed and the Company shall issue a
certificate without such Legend to the holder of any Security upon which it is
stamped, and a certificate for a security shall be originally issued without the
Legend, if, unless otherwise required by state securities laws, (i) the sale of
such Security is registered under the 1933 Act or (ii) such holder provides the
Company with an opinion by counsel reasonably satisfactory to the Company, that
is in form, substance and scope reasonably satisfactory to the Company, to the
effect that a public sale or transfer of such Security may be made without
registration under the 1933 Act or (iii) such holder provides the Company with
assurances reasonably satisfactory to the Company and its counsel, that such
Security can be sold pursuant to Rule 144. The Buyer agrees that its sale of all
Securities, including those represented by a certificate(s) from which the
Legend has been removed, or which were originally issued without the Legend,
shall be made only pursuant to an effective registration statement (and to
deliver a prospectus in connection with such sale) or in compliance with an
exemption from the registration requirements of the 1933 Act. In the event the
Legend is removed from any Security or any Security is issued without the Legend
and thereafter the effectiveness of a registration statement covering the sales
of such Security is suspended or the Company determines that a supplement or
amendment thereto is required by applicable securities laws, then upon
reasonable advance notice to the holder of such Security, the Company shall be
entitled to require that the Legend be placed upon any such Security which
cannot then be sold pursuant to an effective registration statement or Rule 144
or with respect to which the opinion referred to in clause (ii) next above has
not been rendered, which Legend shall be removed when such Security may be sold
pursuant to an effective registration statement or Rule 144 (or such holder
provides the opinion with respect thereto described in clause (ii) next above.

c. Conversion of Debenture. The Buyer shall have the right to convert the
Debenture sold hereunder into Conversion Units by delivering via facsimile an
executed and completed Notice of Conversion (as defined in the Debenture) to the
Company and delivering within two (2) business days thereafter the original
Notice of Conversion and (once it has been fully converted) the original
Debenture being converted by express courier to the Company. Each date on which
a Notice of Conversion is faxed to the Company in accordance with the provisions
hereof shall be deemed a. "Conversion Date". The Company will transmit the
certificates representing the shares of Common Stock and Warrants issuable upon
conversion of the Debenture (along with a replacement Debenture representing the
amount of principal of said Debenture not so converted, if applicable) to the
Buyer via express courier, within three (3) business days after the relevant
Conversion Date (with respect to each conversion, the "Deadline").

6. CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL.

The obligation of the Company hereunder to sell the Debenture at the Closing is
subject to the satisfaction, on or before the Closing Date, of each of the
following conditions, provided that these conditions are for the Company's sole
benefit and may be waived by the Company at any time in its sole discretion:

a. The parties shall have executed this Agreement.

b. The Buyer shall have delivered the Purchase Price.

c. The representations and warranties of the Buyer shall be true and correct in
all material respects as of the date made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
specific date), and the Buyer shall have performed, satisfied and complied in
all material respects with the covenants, agreements and conditions required by
this Agreement to be performed, satisfied or complied with by the Buyer at or
prior to the Closing Date.

d. No statute, rule, regulation, executive order, decree, ruling or injunction
shall have been enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction or any self regulatory
organization having authority over the matters contemplated hereby which
restricts or prohibits the consummation of any of the transactions contemplated
herein.

7. CONDITIONS TO THE BUYER'S OBLIGATION TO PURCHASE.

The obligation of the Buyer to purchase the Debenture is subject to the
satisfaction, on or before the Closing Date, of each of the following
conditions, provided that these conditions are for the sole benefit of the Buyer
and may be waived by the Buyer at any time in its sole discretion:

a. The parties shall have executed this Agreement.

b. The representations and warranties of the Company shall be true and correct
in all material respects as of the date made and as of Closing Date as though
made at that time (except for representations and warranties that speak as of a
specific date) and the Company shall have performed, satisfied and complied in
all material respects with the covenants, agreements and conditions required by
this Agreement to be performed, satisfied or complied with by the Company at or
prior to the Closing Date.

c. With respect to the Closing, the Company shall have issued and have duly
executed by the authorized officers of the Company, and delivered to the Buyer
the Debenture being sold at the Closing.

d. With respect to the Closing, the Company shall have issued and have duly
executed by the authorized officers of the Company, and delivered to the Buyer
the Irrevocable Transfer Agent Instructions at the Closing.

e. No statute, rule, regulation, executive order, decree, ruling or injunction
shall have been enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction or any self regulatory
organization having authority over the matters contemplated hereby which
restricts or prohibits the consummation of any of the transactions contemplated
herein.

8. GOVERNING LAW; MISCELLANEOUS.

a. Governing Law. This Agreement shall be governed by and interpreted in
accordance with the laws of the State of California without regard to the
principles of conflict of laws. In the event of any litigation regarding the
interpretation or application of this Agreement, the parties irrevocably consent
to jurisdiction in any of the state or federal courts located in San Diego,
California and waive their rights to object to venue in any such court,
regardless of the convenience or inconvenience thereof to any party. Service of
process in any civil action relating to or arising out of this Agreement
(including also all Exhibits or Addenda hereto) or the transaction(s)
contemplated herein may be accomplished in any manner provided by law. The
parties hereto agree that a final, non-appealable judgment in any such suit or
proceeding shall be conclusive and may be enforced in other jurisdictions by
suit on such judgment or in any other lawful manner.

b. Counterparts. This Agreement may be executed in two or more identical
counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and
signature pages from such counterparts have been delivered to the Escrow Agent
on behalf of the other party. In the event any signature page is delivered by
facsimile transmission (which the parties agree is an acceptable form of
delivery), the party using such means of delivery shall cause an additional
originally executed signature page to be physically delivered to the other party
within two (2) business days of the execution and delivery of the facsimile
signature.

c. Headings: Gender Etc. The headings of this Agreement are for convenience of
reference and shall not form a part of; or affect the interpretation of this
Agreement. As used herein, the masculine shall refer to the feminine and neuter,
the feminine to the masculine and neuter, and the neuter to the masculine and
feminine, as the context may require. As used herein, unless the context clearly
requires otherwise, the words "herein " "hereunder" and "hereby," shall refer to
this entire Agreement and not only to the Section or paragraph in which such
word appears. If any date specified herein falls upon a Saturday, Sunday or
public or legal holidays, the date shall be construed to mean the next business
day following such Saturday, Sunday or public or legal holiday. For purposes of
this Agreement, a "business day" is any day other than a Saturday, Sunday or
public or legal holiday.

d. Severability. If any provision of this Agreement shall be invalid or
unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Agreement In that
jurisdiction or the validity or enforceability of any provision of this
Agreement in any other jurisdiction.

e. Entire Agreement; Amendments. This Agreement and the instruments referenced
herein contain the entire understanding of the parties with respect to the
matters covered herein and therein and, except as specifically set forth herein
or therein, neither the Company nor the Buyer makes any representation,
warranty, covenant or undertaking with respect to such matters. No provision of
this Agreement may be waived or amended other than by an instrument in writing
signed by the party to be charged with enforcement.

f. Notices. Any notices required or permitted to he given under the terms of
this Agreement shall be delivered personally or by courier or via facsimile (if
via facsimile, to be followed within three (3) business days by an original of
the notice document via courier) and shall be effective upon receipt, if
delivered personally or by courier or by facsimile, in each case properly
addressed to the party to receive the same. The addresses for such
communications shall he:

If to the Company:         Innovative Medical Services
                           1725 Gillespie Way
                           El Cajon, CA 92020

                           Telephone:       619 596 8600
                           Facsimile:       619 596 8791
                           Attention: Mr. Michael Krall

If to the Buyer, at the address on the signature page of this Agreement. Each
party shall provide ritten notice to the other party of any change in address.

g. Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the parties and their respective successors and assigns. Neither the
Company nor the Buyer shall assign this Agreement or any rights or obligations
hereunder without the prior written consent of the other (which consent shall
not be unreasonably withheld), and in any event any assignee of the Buyer shall
be an accredited investor (as defined in Regulation D), in the written opinion
of counsel who is reasonably satisfactory to the Company and in form, substance
and scope reasonably satisfactory to the Company. Notwithstanding the foregoing,
if applicable, any of the entities constituting the Buyer (if greater than one
(1) entity) may assign its rights hereunder to any of its "affiliates," as that
term is defined under the 1934 Act, without the consent of the Company;
provided, however, that any such assignment shall not release such assigning
entity from its obligations hereunder unless such obligations are assumed by
such affiliate and the Company has prior to such assignment and assumption
consented in writing to the same; and no such assignment shall be made unless it
is made in accordance with any applicable securities laws of any applicable
jurisdiction. Any request for an assignment made hereunder by the Buyer shall be
accompanied by a legal opinion in form, substance and scope reasonably
satisfactory to the Company, that such assignment is proper under applicable
law. Notwithstanding anything herein to the contrary, Buyer may pledge the
Securities as collateral for a bona fide loan pursuant to a security agreement
with a third party lender, and such pledge shall not be considered an assignment
in violation of ails Agreement so long as it is made in compliance with all
applicable law.

h. No Third Party Beneficiaries. This Agreement is intended for the benefit of
the parties hereto and their respective permitted successors and assigns, and is
not for the benefit of, nor may any provision hereof be enforced by, any other
person.

i. Survival. Unless this Agreement is terminated under Section 8(k), the
representations and warranties of the Company and the Buyer contained in
Sections 2 and 3 and the agreements and covenants set forth in Sections 4, 5 and
8 shall survive the Closing of the purchase and sale of Securities purchased and
sold hereby.

j. Further Assurance. Each party shall do and perform, or cause to be done and
performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents, as the other
party may reasonably request in order to carry out the intent and accomplish the
purposes of this Agreement and the consummation of the transactions contemplated
hereby.

k. Termination. In the event that the Closing shall not have occurred on or
before ten (10) business days from the date hereof this Agreement shall
terminate at the close of business on such date. Neither party may unilaterally
terminate this Agreement after the Closing for any reason other than a material
breach of this Agreement by the non-terminating party. Such termination shall
not be the sole remedy for a breach of this Agreement by the non-terminating
patty, and each party shall retain all of its rights hereunder at law or in
equity. Notwithstanding anything herein to the contrary, a party whose breach of
a covenant or representation and warranty or failure to satisfy a condition
prevented the Closing shall not be entitled to terminate this Agreement.

<PAGE>

l. Remedies. No provision of this Agreement providing for any specific remedy to
a party shall be construed to limit such party to the specific remedy described,
and any other remedy that would otherwise be available to such party at law or
in equity shall be so available. Nothing in this Agreement shall limit any
rights a party may have with any applicable federal or state securities laws
with respect to the transactions contemplated hereby.

IN WITNESS WHEREOF, the Buyer and the Company have caused this Securities
Purchase Agreement to be duly executed as of the date first written above.

COMPANY:          Innovative Medical Services

                   By:
                         Mr. Michael Krall, President & Chief Executive Officer

                  BUYER:   xxxxxxxxxxxxxxxxxxxx.
                           ---------------------

                  By:
                           -----------------------------------
                           Alfred Peeper, Authorized Representative

         BUYER'S ADDRESS:               (with copy to:)

         xxxxxxxxxxxxxxxxxxxx            Alfred Peeper
         xxxxxxxxxxxxxxxxxxxx            Calle Hamburgo 22
         xxxxxxxxxxxxxxxxxxxx            Edificio 2-4
         xxxxxxxxxxxxxxxxxxxx            03500 Beniform-Alicante, Spain
         xxxxxxxxxxxxxx                  Fax # 011 34 96 683 0719Exhibit 4.2
                      Specimen Warrant Issued to Directors

No.                                                            Right to Purchase
    ----                                                       250,000 shares

                         Raven Moon International, Inc.
               Incorporated under the Laws of the State of Florida

                             Stock Purchase Warrant
                        Void after 3 p.m., April 17, 2003

     This is to certify that the holder is entitled to purchase, on or before
April 17, 2003, at 3 p.m., 250,000 shares of the above Company, at a price equal
to 80% of the average price of said shares on the opening day of trading after
the date of issuance of this warrant, upon presentation of this warrant and
payment of the purchase price at the office of the Company. This warrant is
subject to the statement of rights of warrant holders printed on the reverse
hereof, which is incorporated herein by reference, and to which the holder
hereof assents to by acceptance of this warrant.

     This warrant is issued to _________ is transferable by assignment. By
accepting this warrant, the holder agrees that the Company may treat any
subsequent assignee as absolute owner for all purposes, notwithstanding any
notice to the contrary.

     This warrant shall be void unless the subscription right herein granted is
exercised on or before 3 p.m., April 17, 2003 .

Corporate Seal                              Raven Moon International, Inc.
Attest:

                                            By:
------------------------                       ----------------------------
Bernadette DiFrancesco, Secretary              Joey DiFrancesco, President

Date:  April 5, 2000
                    --------

<PAGE>

                     Statement of Rights of Warrant Holders

1.   Reservation of stock. The Company covenants that, while the warrants are
     exercisable, it will reserve from its authorized and unissued common stock
     a sufficient number of shares to provide for the delivery of stock pursuant
     to the exercise of this and all other similar warrants.

2.   Protection against dilution. In any of the following events, occurring
     hereinafter, appropriate adjustment shall be made in the number of shares
     deliverable upon the exercise of this warrant or the price per share to be
     paid, so as to maintain the proportionate interest of each warrant holder:
     (a) recapitalization of the Company through a split-up of the outstanding
     shares of common stock or a combination of the outstanding shares into a
     lesser number; (b) declaration of a dividend on the common stock or
     securities convertible into common stock; or (c) issuance of common stock
     at less than the price per share payable upon the exercise of this warrant.

3.   Merger. In case the Company, or any successor, shall be consolidated or
     merged with another company, or substantially all of its assets shall be
     sold to another company in exchange for stock with the view to distributing
     such stock to its stockholders, each share of stock purchasable by this
     warrant shall be replaced for the purposes hereof by the securities or
     property issuable or distributable in respect of one share of common stock
     of this Company, or its successors, upon such consolidation, merger, or
     sale, and adequate provision to that effect shall be made at the time
     thereof.

4.   Stockholders' rights. Until the valid exercise of this warrant, the holder
     hereof shall not be entitled to any rights of a stockholder; but
     immediately upon the exercise of this warrant and upon payment as provided
     herein, the holder hereof shall be deemed a record holder of the common
     stock.

5.   Divisibility of warrant. This warrant may be divided into warrants of one
     share or multiples thereof, upon surrender at the office of the Company or
     its warrant agent.

6.   Fractional warrants. Upon the exercise of this warrant, no fractions of
     shares shall be issued; but fractional warrants will be delivered,
     entitling the holder, upon surrender with other fractional warrants
     aggregating one or more full shares, to purchase such full shares.

7.   Negotiability. Title to this warrant shall pass by assignment, in the same
     manner as a negotiable instrument payable to the holder. The holder hereof,
     pursuant to any valid assignment, may be treated by the Company and all
     other persons as the absolute owner for all purposes and entitled to
     exercise this warrant or to transfer title to same.

8.   Term. This warrant shall become void unless the rights hereunder are
     exercised and payment made prior to 3 p.m., April 17, 2000; provided that
     in case of the earlier dissolution of the Company, this warrant shall
     become void on the date fixed for such dissolution.

                              Form of Subscription
                  (To be signed only upon exercise of Warrant)

To: Raven Moon International, Inc.

     The undersigned, the owner of the within warrant, hereby irrevocably elects
to exercise the purchase rights represented by this warrant for, and to purchase
thereunder,_________shares of common stock of Raven Moon International, Inc.,
and herewith makes payment of $_________therefor, and requests that the
certificates for such shares be issued in the name of and be delivered to
,____________________ whose address is ,_________________________ and if such
shares shall not be all of the shares purchasable hereunder be delivered to the
undersigned.

Dated:
      --------------------

                               Form of Assignment

     The undersigned does hereby assign to ,______________________ whose address
___________________________________ is , the rights and privileges evidenced by
this certificate effective this day of ,__________________________
___________________________ 20______.

Assignor:_____________________________ Print name: _____________________

Witness:______________________________ Print name: _____________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}]]